# Ataxion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ataxion

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Total disclosed funding: $12M
- Latest round: Series A (Feb 14, 2014)
- Investors on record: 2

## About

Ataxion was founded in 2013 is based in the US and is a biopharmaceutical company that develops therapies for rare, neurologic diseases.

## Funding rounds

- Series A, Feb 14, 2014, $12M — Atlas Venture, Biogen, Inc.

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A
- Biogen, Inc. — Series A